Background: Ischemia-modified albumin (IMA) is a new marker of myocardial ischemia,
there is concern that IMA concentrations may be affected by ischemia occurring in tissues …

Objectives: We examined whether ischemia-modified albumin (IMA) plasma levels change
during exercise stress testing (EST) in patients with known coronary artery disease and …

Ischemia-modified albumin (IMA) has been proposed as a biological marker of myocardial
ischemia (1, 2). Exposure to ischemic myocardium modifies circulating albumin at its NH2 …

Background: Ischemia-modified albumin (IMA) is an emerging marker of ischemia. To
investigate the applicability of IMA for the diagnosis of skeletal muscle ischemia, we …

The diagnosis of cardiac ischemia remains a challenge in contemporary emergency
medicine. A blood-borne biomarker is an attractive alternative to cardiac imaging or stress …

The measurement of cardiac troponins has emerged as the biochemical “gold standard” for
the diagnosis and management of patients with acute chest pain. However, earlier markers …

Objectives Ischemia-modified albumin (IMA), a new serum biomarker of myocardial
ischemia, has been introduced in the diagnosis of acute coronary syndrome. However, few …

OBJECTIVES: Ischaemia modified albumin (IMA) has been used as a marker of myocardial
ischaemia but little is known about its production during ischaemia of other tissues. The …

BACKGROUND: Ischemia-modified albumin (IMA) has been shown to be a rapidly rising
and sensitive biochemical marker for the diagnosis of myocardial ischemia. In this study, we …

Objective: Ischemia-modified albumin (IMA®) is a novel marker for assessing cardiac
ischaemia. We assessed the relationship between total albumin concentrations and IMA in …